Vitiligo is an autoimmune depigment disease results from extensive melanocytes
destruction. The destruction of melanocyte is thought to be of multifactorial causation …

Vitiligo is a hypomelanotic autoimmune skin disease arising from a breakdown in
immunological self-tolerance, which leads to aberrant immune responses against …

Vitiligo is an autoimmune disease of the skin that results in disfiguring white spots. There are
no US Food and Drug Administration–approved treatments for vitiligo, and most off-label …

Vitiligo melanocytes possess higher susceptibility to oxidative insults. Consistent with this,
impairment of the antioxidant defense system has been reported to be involved in the onset …

IL-17 is involved in the pathogenesis of several autoimmune diseases; however its role in
vitiligo has not been well defined. Emerging human and mouse studies have demonstrated …

Vitiligo is a T cell–mediated inflammatory skin disorder characterized by the loss of
epidermal melanocytes. However, the contribution of melanocytes to the physiopathology of …

Summary Interleukin (IL)‐17 is an emerging target for inflammatory skin disorders. Given the
remarkable success of its therapeutic inhibition in psoriasis, the pathogenic role of this …

Vitiligo is a skin disorder with melanocyte destruction and an autoimmune basis. Given the
importance of cytokines in autoimmunity, we aimed to find the cytokine profile of innate and …

Vitiligo is an acquired dermatological disease frequently associated with autoimmune
thyroid disorders. Several theories have been proposed so far to unravel the complex vitiligo …

Vitiligo is a chronic stigmatizing disease, already known for millennia, which mainly affects
melanocytes from epidermis basal layer, leading to the development of hypochromic and …